BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8864318)

  • 1. Pharmacokinetics of bismuth and ranitidine following single doses of ranitidine bismuth citrate.
    Koch KM; Davis IM; Gooding AE; Yin Y
    Br J Clin Pharmacol; 1996 Aug; 42(2):201-5. PubMed ID: 8864318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of bismuth and ranitidine following multiple doses of ranitidine bismuth citrate.
    Koch KM; Kerr BM; Gooding AE; Davis IM
    Br J Clin Pharmacol; 1996 Aug; 42(2):207-11. PubMed ID: 8864319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of bismuth in the rat after oral dosing with ranitidine bismuth citrate and bismuth subcitrate.
    Canena J; Reis J; Pinto AS; Santos AM; Leitão J; Pinheiro T; Quina MG
    J Pharm Pharmacol; 1998 Mar; 50(3):279-83. PubMed ID: 9600719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacokinetics of bismuth from ranitidine bismuth citrate (GR122311X), a novel anti-ulcerant and tripotassium dicitrato bismuthate (TDB).
    Lacey LF; Frazer NM; Keene ON; Smith JT
    Eur J Clin Pharmacol; 1994; 47(2):177-80. PubMed ID: 7859806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling of trough plasma bismuth concentrations.
    Bennett JE; Wakefield JC; Lacey LF
    J Pharmacokinet Biopharm; 1997 Feb; 25(1):79-106. PubMed ID: 9353695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and bioequivalence of ranitidine and bismuth derived from two compound preparations.
    Zhou Q; Ruan ZR; Yuan H; Jiang B; Xu DH
    World J Gastroenterol; 2006 May; 12(17):2742-8. PubMed ID: 16718762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of administration of ranitidine bismuth citrate with food on the suppression and eradication of Helicobacter pylori in infected volunteers.
    Webb DD; Ciociola AA; Perschy TB; Goodwin BB
    Am J Gastroenterol; 1995 Aug; 90(8):1273-7. PubMed ID: 7639229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten-day triple therapy with ranitidine bismuth citrate, amoxicillin, and clarithromycin in eradicating Helicobacter pylori.
    Vakil N; Cutler A
    Am J Gastroenterol; 1999 May; 94(5):1197-9. PubMed ID: 10235192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ranitidine bismuth citrate and ranitidine do not affect gastric emptying of a radio-labelled liquid meal.
    Parikh R; Sweetland J; Forster ER; Bedding AW; Farr SJ; Smith JT
    Br J Clin Pharmacol; 1994 Dec; 38(6):577-80. PubMed ID: 7888296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ranitidine bismuth citrate and aspirin-induced gastric mucosal injury.
    Hudson N; Murray FE; Cole AT; Turnbull GM; Lettis S; Hawkey CJ
    Aliment Pharmacol Ther; 1993 Oct; 7(5):515-21. PubMed ID: 7904188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal and systemic uptake of bismuth in mice after oral exposure.
    Larsen A; Martiny N; Stoltenberg M; Danscher G; Rungby J
    Pharmacol Toxicol; 2003 Aug; 93(2):82-90. PubMed ID: 12899670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six-day therapy with ranitidine bismuth citrate plus low-dose clarithromycin and tinidazole to cure Helicobacter pylori infection.
    Cammarota G; Cannizzaro O; Cianci R; Gasbarrini A; Pirozzi G; Gasbarrini G
    Hepatogastroenterology; 2000; 47(34):1176-9. PubMed ID: 11020908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric persorption of bismuth from ranitidine bismuth citrate.
    Fraser AG; Lewin JF; Pounder RE
    Aliment Pharmacol Ther; 1995 Aug; 9(4):447-50. PubMed ID: 8527622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of ranitidine bismuth citrate plus amoxycillin and clarithromycin as first- or second-line therapy to cure Helicobacter pylori infection.
    Tursi A; Brandimarte G; Giorgetti G; Modeo ME; Gigliobianco A
    Hepatogastroenterology; 2002; 49(46):1006-9. PubMed ID: 12143188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of ranitidine and nizatidine in very elderly patients.
    Sasaki M; Sudoh T; Fujimura A
    Am J Ther; 2005; 12(3):223-5. PubMed ID: 15891265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ranitidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals duodenal ulcers.
    Bardhan KD; Wurzer H; Marcelino M; Jahnsen J; Lotay N; Roberts PM
    Am J Gastroenterol; 1998 Mar; 93(3):380-5. PubMed ID: 9517644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Da-Cheng-Qi decoction on the pharmacokinetics of ranitidine in rats.
    Tang WF; Wan MH; Huang QR; Zhu ZY; Zhao JL; Wu YZ; Huang X
    Biomed Chromatogr; 2008 Aug; 22(8):851-6. PubMed ID: 18384065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ranitidine bismuth citrate in the treatment of Helicobacter pylori infection and duodenal ulcer.
    Vondracek TG
    Ann Pharmacother; 1998 Jun; 32(6):672-9. PubMed ID: 9640487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ranitidine bismuth citrate plus clarithromycin for the eradication of H. pylori.
    Dixon JS; Pipkin GA; Mills JG; Wood JR
    J Physiol Pharmacol; 1997 Sep; 48 Suppl 4():47-58. PubMed ID: 9440055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ranitidine bismuth citrate with clarithromycin for the treatment of duodenal ulcer.
    Bardhan KD; Dallaire C; Eisold H; Duggan AE
    Gut; 1997 Aug; 41(2):181-6. PubMed ID: 9301496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.